消化器疾患治療薬市場は、2023年から2028年にかけて185億2,610万米ドル成長すると予測されており、予測期間中に6.81%のCAGRで加速すると予測されています。このレポートは、全体的な分析、市場規模と予測、傾向、成長ドライバー、課題、および約25のベンダーをカバーするベンダー分析を提供します。
このレポートは、現在の市場シナリオ、最新の傾向と推進力、および全体的な市場環境に関する最新の分析を提供します。市場は、消化器疾患の罹患率の増加、消化器治療薬の新製品上市、生物製剤や標的治療薬に対する需要の増加によって牽引されています。
この調査は、栄養療法の利用可能性が、今後数年間の消化器疾患治療薬市場の成長を促進する主な理由の1つであることを特定しています。また、マイクロバイオームベースの治療法の出現と、家庭ベースの治療法と組み合わせたセルフメディケーションの増加により、市場でかなりの需要が発生すると予想されます。
また、本レポートには、市場の成長に影響を与える今後の傾向と課題に関する情報が含まれています。これは、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。
この調査は、業界の主要参加者からの意見を含む一次情報と二次情報を客観的に組み合わせて実施されました。このレポートには、主要ベンダーの分析に加えて、包括的な市場とベンダーの状況が含まれています。
このレポートは、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析による複数のソースからのデータの調査、合成、合計により、市場の詳細な全体像を提示します。業界の主要な影響力を持つ企業を特定することで、さまざまな市場の側面を示します。提示されたデータは包括的で信頼性が高く、一次および二次の両方にわたる広範な研究の結果です。市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用した、完全な競争状況と詳細なベンダー選択方法論および分析を提供します。
目次
Table of Contents
1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Drug Class
Executive Summary - Chart on Market Segmentation by Type
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis
3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global Gastrointestinal Diseases Therapeutics Market 2018 - 2022
Historic Market Size - Data Table on Global Gastrointestinal Diseases Therapeutics Market 2018 - 2022 ($ million)
4.2 Drug Class segment analysis 2018 - 2022
Historic Market Size - Drug Class Segment 2018 - 2022 ($ million)
4.3 Type segment analysis 2018 - 2022
Historic Market Size - Type Segment 2018 - 2022 ($ million)
4.4 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Drug Class
6.1 Market segments
Chart on Drug Class - Market share 2023-2028 (%)
Data Table on Drug Class - Market share 2023-2028 (%)
6.2 Comparison by Drug Class
Chart on Comparison by Drug Class
Data Table on Comparison by Drug Class
6.3 Anti-inflammatory and immunosuppressors - Market size and forecast 2023-2028
Chart on Anti-inflammatory and immunosuppressors - Market size and forecast 2023-2028 ($ million)
Data Table on Anti-inflammatory and immunosuppressors - Market size and forecast 2023-2028 ($ million)
Chart on Anti-inflammatory and immunosuppressors - Year-over-year growth 2023-2028 (%)
Data Table on Anti-inflammatory and immunosuppressors - Year-over-year growth 2023-2028 (%)
6.4 Acid neutralizers - Market size and forecast 2023-2028
Chart on Acid neutralizers - Market size and forecast 2023-2028 ($ million)
Data Table on Acid neutralizers - Market size and forecast 2023-2028 ($ million)
Chart on Acid neutralizers - Year-over-year growth 2023-2028 (%)
Data Table on Acid neutralizers - Year-over-year growth 2023-2028 (%)
6.5 Others - Market size and forecast 2023-2028
Chart on Others - Market size and forecast 2023-2028 ($ million)
Data Table on Others - Market size and forecast 2023-2028 ($ million)
Chart on Others - Year-over-year growth 2023-2028 (%)
Data Table on Others - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by Drug Class
Market opportunity by Drug Class ($ million)
Data Table on Market opportunity by Drug Class ($ million)
7 Market Segmentation by Type
7.1 Market segments
Chart on Type - Market share 2023-2028 (%)
Data Table on Type - Market share 2023-2028 (%)
7.2 Comparison by Type
Chart on Comparison by Type
Data Table on Comparison by Type
7.3 Branded - Market size and forecast 2023-2028
Chart on Branded - Market size and forecast 2023-2028 ($ million)
Data Table on Branded - Market size and forecast 2023-2028 ($ million)
Chart on Branded - Year-over-year growth 2023-2028 (%)
Data Table on Branded - Year-over-year growth 2023-2028 (%)
7.4 Generics - Market size and forecast 2023-2028
Chart on Generics - Market size and forecast 2023-2028 ($ million)
Data Table on Generics - Market size and forecast 2023-2028 ($ million)
Chart on Generics - Year-over-year growth 2023-2028 (%)
Data Table on Generics - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by Type
Market opportunity by Type ($ million)
Data Table on Market opportunity by Type ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2023-2028 (%)
Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ million)
Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.5 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Japan - Market size and forecast 2023-2028
Chart on Japan - Market size and forecast 2023-2028 ($ million)
Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Chart on Japan - Year-over-year growth 2023-2028 (%)
Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.9 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ million)
Data Table on China - Market size and forecast 2023-2028 ($ million)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
9.10 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ million)
Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.11 France - Market size and forecast 2023-2028
Chart on France - Market size and forecast 2023-2028 ($ million)
Data Table on France - Market size and forecast 2023-2028 ($ million)
Chart on France - Year-over-year growth 2023-2028 (%)
Data Table on France - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Opportunity/Restraints
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints
11 Competitive Landscape
11.1 Overview
11.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
Overview on factors of disruption
11.4 Industry risks
Impact of key risks on business
12 Competitive Analysis
12.1 Companies profiled
Companies covered
12.2 Market positioning of companies
Matrix on companies position and classification
12.3 Abbott Laboratories
Abbott Laboratories - Overview
Abbott Laboratories - Business segments
Abbott Laboratories - Key news
Abbott Laboratories - Key offerings
Abbott Laboratories - Segment focus
12.4 AbbVie Inc.
AbbVie Inc. - Overview
AbbVie Inc. - Product / Service
AbbVie Inc. - Key news
AbbVie Inc. - Key offerings
12.5 AstraZeneca Plc
AstraZeneca Plc - Overview
AstraZeneca Plc - Product / Service
AstraZeneca Plc - Key news
AstraZeneca Plc - Key offerings
12.6 Bausch Health Companies Inc.
Bausch Health Companies Inc. - Overview
Bausch Health Companies Inc. - Business segments
Bausch Health Companies Inc. - Key news
Bausch Health Companies Inc. - Key offerings
Bausch Health Companies Inc. - Segment focus
12.7 Bayer AG
Bayer AG - Overview
Bayer AG - Business segments
Bayer AG - Key news
Bayer AG - Key offerings
Bayer AG - Segment focus
12.8 Biogen Inc.
Biogen Inc. - Overview
Biogen Inc. - Product / Service
Biogen Inc. - Key news
Biogen Inc. - Key offerings
12.9 Boehringer Ingelheim International GmbH
Boehringer Ingelheim International GmbH - Overview
Boehringer Ingelheim International GmbH - Product / Service
Boehringer Ingelheim International GmbH - Key news
Boehringer Ingelheim International GmbH - Key offerings
12.10 Boston Scientific Corp.
Boston Scientific Corp. - Overview
Boston Scientific Corp. - Business segments
Boston Scientific Corp. - Key news
Boston Scientific Corp. - Key offerings
Boston Scientific Corp. - Segment focus
12.11 Eisai Co. Ltd.
Eisai Co. Ltd. - Overview
Eisai Co. Ltd. - Business segments
Eisai Co. Ltd. - Key offerings
Eisai Co. Ltd. - Segment focus
12.12 GlaxoSmithKline Plc
GlaxoSmithKline Plc - Overview
GlaxoSmithKline Plc - Business segments
GlaxoSmithKline Plc - Key news
GlaxoSmithKline Plc - Key offerings
GlaxoSmithKline Plc - Segment focus
12.13 Johnson and Johnson Services Inc.
Johnson and Johnson Services Inc. - Overview
Johnson and Johnson Services Inc. - Business segments
Johnson and Johnson Services Inc. - Key news
Johnson and Johnson Services Inc. - Key offerings
Johnson and Johnson Services Inc. - Segment focus
12.14 Merck and Co. Inc.
Merck and Co. Inc. - Overview
Merck and Co. Inc. - Business segments
Merck and Co. Inc. - Key news
Merck and Co. Inc. - Key offerings
Merck and Co. Inc. - Segment focus
12.15 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
12.16 UCB SA
UCB SA - Overview
UCB SA - Product / Service
UCB SA - Key offerings
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
13.3 Currency conversion rates for US$
Currency conversion rates for US$
13.4 Research methodology
Research methodology
13.5 Data procurement
Information sources
13.6 Data validation
Data validation
13.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
13.8 Data synthesis
Data synthesis
13.9 360 degree market analysis
360 degree market analysis
13.10 List of abbreviations
List of abbreviations
Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibits6: Executive Summary - Chart on Market Segmentation by Type
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Company Market Positioning
Exhibits10: Parent Market
Exhibits11: Data Table on - Parent Market
Exhibits12: Market characteristics analysis
Exhibits13: Value Chain Analysis
Exhibits14: Offerings of companies included in the market definition
Exhibits15: Market segments
Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits20: Historic Market Size - Data Table on Global Gastrointestinal Diseases Therapeutics Market 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Drug Class Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Type Segment 2018 - 2022 ($ million)
Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits25: Five forces analysis - Comparison between 2023 and 2028
Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits31: Chart on Market condition - Five forces 2023 and 2028
Exhibits32: Chart on Drug Class - Market share 2023-2028 (%)
Exhibits33: Data Table on Drug Class - Market share 2023-2028 (%)
Exhibits34: Chart on Comparison by Drug Class
Exhibits35: Data Table on Comparison by Drug Class
Exhibits36: Chart on Anti-inflammatory and immunosuppressors - Market size and forecast 2023-2028 ($ million)
Exhibits37: Data Table on Anti-inflammatory and immunosuppressors - Market size and forecast 2023-2028 ($ million)
Exhibits38: Chart on Anti-inflammatory and immunosuppressors - Year-over-year growth 2023-2028 (%)
Exhibits39: Data Table on Anti-inflammatory and immunosuppressors - Year-over-year growth 2023-2028 (%)
Exhibits40: Chart on Acid neutralizers - Market size and forecast 2023-2028 ($ million)
Exhibits41: Data Table on Acid neutralizers - Market size and forecast 2023-2028 ($ million)
Exhibits42: Chart on Acid neutralizers - Year-over-year growth 2023-2028 (%)
Exhibits43: Data Table on Acid neutralizers - Year-over-year growth 2023-2028 (%)
Exhibits44: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibits45: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibits46: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits47: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits48: Market opportunity by Drug Class ($ million)
Exhibits49: Data Table on Market opportunity by Drug Class ($ million)
Exhibits50: Chart on Type - Market share 2023-2028 (%)
Exhibits51: Data Table on Type - Market share 2023-2028 (%)
Exhibits52: Chart on Comparison by Type
Exhibits53: Data Table on Comparison by Type
Exhibits54: Chart on Branded - Market size and forecast 2023-2028 ($ million)
Exhibits55: Data Table on Branded - Market size and forecast 2023-2028 ($ million)
Exhibits56: Chart on Branded - Year-over-year growth 2023-2028 (%)
Exhibits57: Data Table on Branded - Year-over-year growth 2023-2028 (%)
Exhibits58: Chart on Generics - Market size and forecast 2023-2028 ($ million)
Exhibits59: Data Table on Generics - Market size and forecast 2023-2028 ($ million)
Exhibits60: Chart on Generics - Year-over-year growth 2023-2028 (%)
Exhibits61: Data Table on Generics - Year-over-year growth 2023-2028 (%)
Exhibits62: Market opportunity by Type ($ million)
Exhibits63: Data Table on Market opportunity by Type ($ million)
Exhibits64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits65: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits66: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits67: Chart on Geographic comparison
Exhibits68: Data Table on Geographic comparison
Exhibits69: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits70: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits71: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits72: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits73: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits74: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits75: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits76: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits77: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits78: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits79: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits80: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits81: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits82: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits83: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits84: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits85: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits86: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits87: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits88: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits89: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits90: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits91: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits92: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits93: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits94: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits95: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits96: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits97: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits98: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits99: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits100: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits101: Chart on France - Market size and forecast 2023-2028 ($ million)
Exhibits102: Data Table on France - Market size and forecast 2023-2028 ($ million)
Exhibits103: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibits104: Data Table on France - Year-over-year growth 2023-2028 (%)
Exhibits105: Market opportunity By Geographical Landscape ($ million)
Exhibits106: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits107: Impact of drivers and challenges in 2023 and 2028
Exhibits108: Overview on criticality of inputs and factors of differentiation
Exhibits109: Overview on factors of disruption
Exhibits110: Impact of key risks on business
Exhibits111: Companies covered
Exhibits112: Matrix on companies position and classification
Exhibits113: Abbott Laboratories - Overview
Exhibits114: Abbott Laboratories - Business segments
Exhibits115: Abbott Laboratories - Key news
Exhibits116: Abbott Laboratories - Key offerings
Exhibits117: Abbott Laboratories - Segment focus
Exhibits118: AbbVie Inc. - Overview
Exhibits119: AbbVie Inc. - Product / Service
Exhibits120: AbbVie Inc. - Key news
Exhibits121: AbbVie Inc. - Key offerings
Exhibits122: AstraZeneca Plc - Overview
Exhibits123: AstraZeneca Plc - Product / Service
Exhibits124: AstraZeneca Plc - Key news
Exhibits125: AstraZeneca Plc - Key offerings
Exhibits126: Bausch Health Companies Inc. - Overview
Exhibits127: Bausch Health Companies Inc. - Business segments
Exhibits128: Bausch Health Companies Inc. - Key news
Exhibits129: Bausch Health Companies Inc. - Key offerings
Exhibits130: Bausch Health Companies Inc. - Segment focus
Exhibits131: Bayer AG - Overview
Exhibits132: Bayer AG - Business segments
Exhibits133: Bayer AG - Key news
Exhibits134: Bayer AG - Key offerings
Exhibits135: Bayer AG - Segment focus
Exhibits136: Biogen Inc. - Overview
Exhibits137: Biogen Inc. - Product / Service
Exhibits138: Biogen Inc. - Key news
Exhibits139: Biogen Inc. - Key offerings
Exhibits140: Boehringer Ingelheim International GmbH - Overview
Exhibits141: Boehringer Ingelheim International GmbH - Product / Service
Exhibits142: Boehringer Ingelheim International GmbH - Key news
Exhibits143: Boehringer Ingelheim International GmbH - Key offerings
Exhibits144: Boston Scientific Corp. - Overview
Exhibits145: Boston Scientific Corp. - Business segments
Exhibits146: Boston Scientific Corp. - Key news
Exhibits147: Boston Scientific Corp. - Key offerings
Exhibits148: Boston Scientific Corp. - Segment focus
Exhibits149: Eisai Co. Ltd. - Overview
Exhibits150: Eisai Co. Ltd. - Business segments
Exhibits151: Eisai Co. Ltd. - Key offerings
Exhibits152: Eisai Co. Ltd. - Segment focus
Exhibits153: GlaxoSmithKline Plc - Overview
Exhibits154: GlaxoSmithKline Plc - Business segments
Exhibits155: GlaxoSmithKline Plc - Key news
Exhibits156: GlaxoSmithKline Plc - Key offerings
Exhibits157: GlaxoSmithKline Plc - Segment focus
Exhibits158: Johnson and Johnson Services Inc. - Overview
Exhibits159: Johnson and Johnson Services Inc. - Business segments
Exhibits160: Johnson and Johnson Services Inc. - Key news
Exhibits161: Johnson and Johnson Services Inc. - Key offerings
Exhibits162: Johnson and Johnson Services Inc. - Segment focus
Exhibits163: Merck and Co. Inc. - Overview
Exhibits164: Merck and Co. Inc. - Business segments
Exhibits165: Merck and Co. Inc. - Key news
Exhibits166: Merck and Co. Inc. - Key offerings
Exhibits167: Merck and Co. Inc. - Segment focus
Exhibits168: Pfizer Inc. - Overview
Exhibits169: Pfizer Inc. - Product / Service
Exhibits170: Pfizer Inc. - Key news
Exhibits171: Pfizer Inc. - Key offerings
Exhibits172: UCB SA - Overview
Exhibits173: UCB SA - Product / Service
Exhibits174: UCB SA - Key offerings
Exhibits175: Inclusions checklist
Exhibits176: Exclusions checklist
Exhibits177: Currency conversion rates for US$
Exhibits178: Research methodology
Exhibits179: Information sources
Exhibits180: Data validation
Exhibits181: Validation techniques employed for market sizing
Exhibits182: Data synthesis
Exhibits183: 360 degree market analysis
Exhibits184: List of abbreviations
